Immediate Impact
3 by Nobel laureates 10 from Science/Nature 68 standout
Citing Papers
The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
2025 Standout
Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy
2023 StandoutNobel
Works of RS Finn being referenced
LBA36 Final analysis of RATIONALE-301: Randomized, phase III study of tislelizumab versus sorafenib as first-line treatment for unresectable hepatocellular carcinoma
2022
A phase Ib trial of lenvatinib (LEN) plus pembrolizumab (PEMBRO) in unresectable hepatocellular carcinoma (uHCC): Updated results
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| RS Finn | 573 | 365 | 224 | 40 | 778 | |
| J.M.G.H. van Riel | 708 | 408 | 375 | 25 | 968 | |
| Jia Luo | 502 | 443 | 280 | 63 | 966 | |
| G. R. Blumenschein | 606 | 509 | 175 | 54 | 986 | |
| J. Jac | 220 | 422 | 203 | 25 | 751 | |
| Muaiad Kittaneh | 440 | 306 | 143 | 40 | 722 | |
| Anne‐Claire Voegeli | 346 | 448 | 151 | 25 | 742 | |
| Chin‐Tung Chen | 569 | 257 | 149 | 22 | 974 | |
| Álvaro Taus | 528 | 402 | 219 | 61 | 845 | |
| Erwan Pencreach | 342 | 189 | 245 | 35 | 770 | |
| J.P. Delord | 696 | 274 | 161 | 48 | 960 |
All Works
Loading papers...